PER3 AS A BIOMARKER FOR PROGNOSIS OF ER-POSITIVE BREAST CANCER

摘要

The present application demonstrates that PER3 is a prognostic biomarker for hormone receptor positive breast cancer. The invention therefore provides, among other aspects, methods of prognosis for breast cancers, methods of assigning treatment for breast cancer, methods of identifying therapeutic agents for breast cancers, and kits to perform the methods provided herein.